Papers
1
Total Citations
7
H-Index
1
About
Dr. F. Subtil is a prominent figure in urologic oncology, whose research centers on the comparative effectiveness of minimally invasive treatments for localized prostate cancer. Their most cited work, a 2018 study, directly compares focal therapy using high-intensity focused ultrasound (HIFU) against robot-assisted radical prostatectomy, providing critical one-year oncological and functional outcomes. This research addresses a pivotal question in modern urology: balancing cancer control with quality of life. By analyzing real-world data, Subtil’s contributions help clarify the trade-offs between these two very different treatment modalities, offering evidence that guides shared decision-making between clinicians and patients. While their citation count (7 for their top paper) reflects a focused, early-stage impact, the study’s clinical relevance is significant, as it tackles the growing demand for less invasive, organ-sparing approaches. Subtil’s work is particularly valuable for researchers and clinicians navigating the evolving landscape of prostate cancer management, where patient-reported outcomes and functional preservation are increasingly paramount. Their findings underscore the need for rigorous, long-term comparative trials to refine treatment algorithms.
Research Focus
Key Achievements
Top Papers
- 1